Sign in

CIK 0001674416 · Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
EIN
473173478
Phone
6173154600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kulkarni Samarth −$2.6M Chief Executive Officer sold 14% of stake
  2. KASINGER JAMES R. −$797K General Counsel and Secretary sold 12% of stake
  3. Behbahani Ali −$781K Director sold 45% of stake
  4. George Simeon −$720K Director sold 48% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-07-01 Novak Rodger President Sale −50,000 $80.00 $4.0M 648,007
2020-06-25 Klein Lawrence Otto CBO & COO Option exercise +4,912 $12.57 $62K 24,912
2020-06-25 Klein Lawrence Otto CBO & COO Sale −4,912 $75.18 $369K 20,000
2020-06-25 Klein Lawrence Otto CBO & COO Option exercise · Stock Option (Right to Buy) −4,912 8,666
2020-06-24 Klein Lawrence Otto CBO & COO Option exercise +38,666 $5.86 $227K 58,666
2020-06-24 Klein Lawrence Otto CBO & COO Sale −15,966 $75.93 $1.2M 42,700
2020-06-24 Klein Lawrence Otto CBO & COO Sale −22,700 $76.50 $1.7M 20,000
2020-06-24 Klein Lawrence Otto CBO & COO Option exercise +26,422 $12.57 $332K 46,422
2020-06-24 Klein Lawrence Otto CBO & COO Sale −6,600 $74.90 $494K 39,822
2020-06-24 Klein Lawrence Otto CBO & COO Sale −3,934 $75.94 $299K 35,888
2020-06-24 Klein Lawrence Otto CBO & COO Sale −800 $76.50 $61K 35,088
2020-06-24 Klein Lawrence Otto CBO & COO Sale −12,175 $75.32 $917K 22,913
2020-06-24 Klein Lawrence Otto CBO & COO Sale −2,913 $76.26 $222K 20,000
2020-06-24 Klein Lawrence Otto CBO & COO Option exercise · Stock Option (Right to Buy) −38,666 0
2020-06-24 Klein Lawrence Otto CBO & COO Option exercise · Stock Option (Right to Buy) −26,422 13,578
2020-06-23 Novak Rodger President Sale −50,000 $75.00 $3.8M 698,007
2020-06-23 Bolzon Bradley J PhD Director Sale −10,000 $75.35 $753K 574,190
2020-06-23 Ho Tony W Executive VP, Head of R&D Sale −6,929 $75.20 $521K 33,747
2020-06-22 Bolzon Bradley J PhD Director Sale −10,000 $72.51 $725K 584,190
2020-06-22 Ho Tony W Executive VP, Head of R&D Sale −229 $70.14 $16K 40,676

Page 42 of 46 · 910 trades